Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| Online-Ressource |
Verfasst von: | Levander, Sepideh [VerfasserIn]  |
| Rupp, Daniel [VerfasserIn]  |
| Long, Gang [VerfasserIn]  |
| Bartenschlager, Ralf [VerfasserIn]  |
Titel: | Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model |
Verf.angabe: | Sepideh Levander, Fredrik Holmström, Lars Frelin, Gustaf Ahlén, Daniel Rupp, Gang Long, Ralf Bartenschlager, Matti Sällberg |
Jahr des Originals: | 2017 |
Umfang: | 11 S. |
Fussnoten: | First published June 23, 2017 ; Gesehen am 28.08.2018 |
Titel Quelle: | Enthalten in: Gut |
Jahr Quelle: | 2018 |
Band/Heft Quelle: | 67(2018), 8, S. 1525-1535 |
ISSN Quelle: | 1468-3288 |
Abstract: | Objective: HCV is characterised by its ability to establish chronic infection in hepatocytes and to replicate in the presence of an inflammation. We mimicked this situation in vivo in immune-competent mice by syngeneic transplantation of HCV replicon-containing mouse hepatoma cells. Design: A total of 5 million H-2b positive Hep56.1D cells, carrying a subgenomic genotype (gt) 2a replicon (HCV replicon cells) or stably expressing comparable levels of the HCV NS3/4A protease/helicase complex (NS3/4A hepatoma cells), were injected subcutaneously into syngeneic H-2b-restricted mice. Kinetics of tumour growth, HCV RNA replication levels and HCV-specific immune responses were monitored. For immune monitoring, new H-2b-restricted cytotoxic T cell epitopes within the gt2a NS3/4A region were mapped. Immune mice were generated by DNA-based vaccination. Results: HCV replicon and NS3/4A hepatoma cells generated solid tumours in vivo. Similar to what is seen in human HCV infection did HCVRNA replicate in the presence of inflammation. NS3/4A-specific CD8+ T cells seemed to transiently reduce HCV RNA levels. Both CD4+ and CD8+ T cells were required for protection against tumour growth. Vaccine-induced NS3/4A(gt2a)-specific T cells protected against HCV replicon tumours in wild-type, but not in HCV NS3/4A(gt1a)-transgenic mice with dysfunctional HCV-specific T cells. Importantly, as in human HCV infection, HCV replicon cells neither primed nor boosted a strong NS3/4A-specific T cell response. Conclusion: Syngeneic transplantation of mouse HCV replicon cells into immune-competent animals mirrors many in vivo events in humans. This system is versatile and can be applied to any genetically modified H-2b-restricted mouse strain. |
DOI: | doi:10.1136/gutjnl-2016-313579 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Kostenfrei: Verlag: http://dx.doi.org/10.1136/gutjnl-2016-313579 |
| Kostenfrei: Verlag: https://gut.bmj.com/content/67/8/1525 |
| DOI: https://doi.org/10.1136/gutjnl-2016-313579 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1580467245 |
Verknüpfungen: | → Zeitschrift |
Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model / Levander, Sepideh [VerfasserIn] (Online-Ressource)
68299624